Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xenophon Kassianides

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMC Nephrology|February 12, 2024
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD - the exploratory randomized controlled double-blind ExplorIRON-CKD studyXenophon Kassianides, Sunil Bhandari
Scientific Reports|October 26, 2023
Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKDXenophon Kassianides, Sunil Bhandari
Kidney & Blood Pressure Research|April 4, 2023
Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney DiseaseXenophon Kassianides, Sunil Bhandari
International Journal of Molecular Sciences|December 23, 2022
Markers of Oxidative Stress, Inflammation and Endothelial Function following High-Dose Intravenous Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease-A Pooled AnalysisXenophon Kassianides, Steven White, Sunil Bhandari
Clinical Kidney Journal|November 9, 2021
Point-of-care testing technologies for the home in chronic kidney disease: a narrative reviewRichard Bodington, Xenophon Kassianides, Sunil Bhandari
The British Journal of Cardiology|June 24, 2022
Cardiac complications in end-stage renal disease: a shared care challengeXenophon Kassianides, Adil Hazara, Sunil Bhandari
Trials|March 19, 2020
Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)Ahmed Ziedan, Xenophon Kassianides, Sunil Bhandari
Expert Review of Hematology|December 15, 2020
An evaluation of ferric derisomaltose as a treatment for anemiaXenophon Kassianides, Richard Bodington, Sunil Bhandari
Expert Opinion on Drug Safety|November 18, 2020
Improving the safety of intravenous iron treatments for patients with chronic kidney diseaseXenophon Kassianides, Adil Mohammad Hazara, Sunil Bhandari
Kidney Research and Clinical Practice|March 22, 2021
The comparative effects of intravenous iron on oxidative stress and inflammation in patients with chronic kidney disease and iron deficiency: a randomized controlled pilot studyXenophon Kassianides, Andrew Gordon, Roger Sturmey, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMC Nephrology|February 12, 2024
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD - the exploratory randomized controlled double-blind ExplorIRON-CKD studyXenophon Kassianides, Sunil Bhandari
Scientific Reports|October 26, 2023
Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKDXenophon Kassianides, Sunil Bhandari
Kidney & Blood Pressure Research|April 4, 2023
Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney DiseaseXenophon Kassianides, Sunil Bhandari
International Journal of Molecular Sciences|December 23, 2022
Markers of Oxidative Stress, Inflammation and Endothelial Function following High-Dose Intravenous Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease-A Pooled AnalysisXenophon Kassianides, Steven White, Sunil Bhandari
Clinical Kidney Journal|November 9, 2021
Point-of-care testing technologies for the home in chronic kidney disease: a narrative reviewRichard Bodington, Xenophon Kassianides, Sunil Bhandari
The British Journal of Cardiology|June 24, 2022
Cardiac complications in end-stage renal disease: a shared care challengeXenophon Kassianides, Adil Hazara, Sunil Bhandari
Trials|March 19, 2020
Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)Ahmed Ziedan, Xenophon Kassianides, Sunil Bhandari
Expert Review of Hematology|December 15, 2020
An evaluation of ferric derisomaltose as a treatment for anemiaXenophon Kassianides, Richard Bodington, Sunil Bhandari
Expert Opinion on Drug Safety|November 18, 2020
Improving the safety of intravenous iron treatments for patients with chronic kidney diseaseXenophon Kassianides, Adil Mohammad Hazara, Sunil Bhandari
Kidney Research and Clinical Practice|March 22, 2021
The comparative effects of intravenous iron on oxidative stress and inflammation in patients with chronic kidney disease and iron deficiency: a randomized controlled pilot studyXenophon Kassianides, Andrew Gordon, Roger Sturmey, et al.
Pageof 2